{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:40:21Z","timestamp":1790779221470,"version":"4.1.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009624","name":"Yonsei University | Yonsei University College of Dentistry","doi-asserted-by":"publisher","award":["6-2024-0004"],"award-info":[{"award-number":["6-2024-0004"]}],"id":[{"id":"10.13039\/501100009624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1C1C1003338"],"award-info":[{"award-number":["NRF-2020R1C1C1003338"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022M3A9F3016364"],"award-info":[{"award-number":["NRF-2022M3A9F3016364"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00406281"],"award-info":[{"award-number":["RS-2024-00406281"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1C1C1003988"],"award-info":[{"award-number":["NRF-2021R1C1C1003988"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64500-0","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T15:00:14Z","timestamp":1764342014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9177-5616","authenticated-orcid":false,"given":"Se-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1725-8210","authenticated-orcid":false,"given":"Kyuwon","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6471-4707","authenticated-orcid":false,"given":"Myunggyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-0594","authenticated-orcid":false,"given":"Wankyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Kwan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakyung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8428-9005","authenticated-orcid":false,"given":"Won-Yoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4795-8537","authenticated-orcid":false,"given":"Yinling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-4032","authenticated-orcid":false,"given":"Haeseung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-7049","authenticated-orcid":false,"given":"Na-Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"64500_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","volume":"19","author":"L Kraehenbuehl","year":"2022","unstructured":"Kraehenbuehl, L., Weng, C. H., Eghbali, S., Wolchok, J. D. & Merghoub, T. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways. Nat. Rev. Clin. Oncol. 19, 37\u201350 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"64500_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2169531","volume":"19","author":"Y Lu","year":"2023","unstructured":"Lu, Y., Zhang, X., Ning, J. & Zhang, M. Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: a systematic evaluation and meta-analysis. Hum. Vaccin. Immunother. 19, 2169531 (2023).","journal-title":"Hum. Vaccin. Immunother."},{"key":"64500_CR3","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1200\/JCO.19.00318","volume":"37","author":"VE Maher","year":"2019","unstructured":"Maher, V. E. et al. Analysis of the association between adverse events and outcome in patients receiving a programmed death protein 1 or programmed death ligand 1 antibody. J. Clin. Oncol. 37, 2730\u20132737 (2019).","journal-title":"J. Clin. Oncol."},{"key":"64500_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins, F. et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat. Rev. Clin. Oncol. 16, 563\u2013580 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"64500_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.alit.2022.01.001","volume":"71","author":"N Okiyama","year":"2022","unstructured":"Okiyama, N. & Tanaka, R. Immune-related adverse events in various organs caused by immune checkpoint inhibitors. Allergol. Int 71, 169\u2013178 (2022).","journal-title":"Allergol. Int"},{"key":"64500_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102455","volume":"19","author":"A Matas-Garcia","year":"2020","unstructured":"Matas-Garcia, A. et al. Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern. Autoimmun. Rev. 19, 102455 (2020).","journal-title":"Autoimmun. Rev."},{"key":"64500_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejca.2017.05.041","volume":"82","author":"D Makarious","year":"2017","unstructured":"Makarious, D., Horwood, K. & Coward, J. I. G. Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors. Eur. J. Cancer 82, 128\u2013136 (2017).","journal-title":"Eur. J. Cancer"},{"key":"64500_CR8","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","volume":"39","author":"BJ Schneider","year":"2021","unstructured":"Schneider, B. J. et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO Guideline update. J. Clin. Oncol. 39, 4073\u20134126 (2021).","journal-title":"J. Clin. Oncol."},{"key":"64500_CR9","doi-asserted-by":"publisher","unstructured":"Tomsitz, D., Ruf, T., S. Zierold, S., French, L. E. & Heinzerling, L. Steroid-refractory immune-related adverse events induced by checkpoint inhibitors. Cancers (Basel) 15, https:\/\/doi.org\/10.3390\/cancers15092538 (2023).","DOI":"10.3390\/cancers15092538"},{"key":"64500_CR10","doi-asserted-by":"publisher","unstructured":"Meza-Valderrama, D. et al. Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer. Nutrients 13, https:\/\/doi.org\/10.3390\/nu13030761i (2021).","DOI":"10.3390\/nu13030761i"},{"key":"64500_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C. & Fearon, K. C. H. Cancer-associated cachexia. Nat. Rev. Dis. Prim. 4, 17105 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"64500_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-024-00786-4","volume":"25","author":"P Altea-Manzano","year":"2025","unstructured":"Altea-Manzano, P., Decker-Farrell, A., Janowitz, T. & Erez, A. Metabolic interplays between the tumour and the host shape the tumour macroenvironment. Nat. Rev. Cancer 25, 274\u2013292 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"64500_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.960341","volume":"10","author":"M Ferrara","year":"2022","unstructured":"Ferrara, M., Samaden, M., Ruggieri, E. & Venereau, E. Cancer cachexia as a multiorgan failure: reconstruction of the crime scene. Front Cell Dev. Biol. 10, 960341 (2022).","journal-title":"Front Cell Dev. Biol."},{"key":"64500_CR14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles, J. M., Busquets, S., Stemmler, B. & Lopez-Soriano, F. J. Cancer cachexia: understanding the molecular basis. Nat. Rev. Cancer 14, 754\u2013762 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"64500_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","volume":"170","author":"HJ Patel","year":"2017","unstructured":"Patel, H. J. & Patel, B. M. TNF-alpha and cancer cachexia: molecular insights and clinical implications. Life Sci. 170, 56\u201363 (2017).","journal-title":"Life Sci."},{"key":"64500_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1172\/JCI115767","volume":"89","author":"G Strassmann","year":"1992","unstructured":"Strassmann, G., Fong, M., Kenney, J. S. & Jacob, C. O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Investig. 89, 1681\u20131684 (1992).","journal-title":"J. Clin. Investig."},{"key":"64500_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00262-021-02997-2","volume":"71","author":"H Jo","year":"2022","unstructured":"Jo, H. et al. Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab. Cancer Immunol. Immunother. 71, 387\u2013398 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"64500_CR18","volume":"1","author":"T Miyawaki","year":"2020","unstructured":"Miyawaki, T. et al. Desensitizing effect of cancer cachexia on immune checkpoint inhibitors in patients with advanced NSCLC. JTO Clin. Res. Rep. 1, 100020 (2020).","journal-title":"JTO Clin. Res. Rep."},{"key":"64500_CR19","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.18632\/aging.205652","volume":"16","author":"Y Yu","year":"2024","unstructured":"Yu, Y., Yan, L., Huang, T., Wu, Z. & Liu, J. Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients. Aging (Albany, NY) 16, 5354\u20135369 (2024).","journal-title":"Aging (Albany, NY)"},{"key":"64500_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","volume":"6","author":"G Kichenadasse","year":"2020","unstructured":"Kichenadasse, G. et al. Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer. JAMA Oncol. 6, 512\u2013518 (2020).","journal-title":"JAMA Oncol."},{"key":"64500_CR21","doi-asserted-by":"publisher","unstructured":"A. Cortellini et al. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >\/= 50%: a multicenter study with external validation. J. Immunother. Cancer 8, (2020). https:\/\/doi.org\/10.1136\/jitc-2020-001403","DOI":"10.1136\/jitc-2020-001403"},{"key":"64500_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5483\/BMBRep.2023-0064","volume":"56","author":"SY Park","year":"2023","unstructured":"Park, S. Y., Hwang, B. O. & Song, N. Y. The role of myokines in cancer: crosstalk between skeletal muscle and tumor. BMB Rep. 56, 365\u2013373 (2023).","journal-title":"BMB Rep."},{"key":"64500_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20123-1","volume":"12","author":"R Sartori","year":"2021","unstructured":"Sartori, R., Romanello, V. & Sandri, M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat. Commun. 12, 330 (2021).","journal-title":"Nat. Commun."},{"key":"64500_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.03.009","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell https:\/\/doi.org\/10.1016\/j.ccell.2024.03.009 (2024).","journal-title":"Cancer Cell"},{"key":"64500_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","volume":"484","author":"SK Shukla","year":"2020","unstructured":"Shukla, S. K. et al. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett. 484, 29\u201339 (2020).","journal-title":"Cancer Lett."},{"key":"64500_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-023-01429-1","volume":"16","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J. Hematol. Oncol. 16, 30 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"64500_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51873-x","volume":"15","author":"Y Hayashi","year":"2024","unstructured":"Hayashi, Y. et al. IL36G-producing neutrophil-like monocytes promote cachexia in cancer. Nat. Commun. 15, 7662 (2024).","journal-title":"Nat. Commun."},{"key":"64500_CR28","doi-asserted-by":"publisher","first-page":"114467","DOI":"10.1016\/j.biopha.2023.114467","volume":"161","author":"SK Ng","year":"2023","unstructured":"Ng, S. K. et al. The protective effect of cannabinoids against colorectal cancer cachexia through modulation of inflammation and immune responses. Biomed. Pharmacother. 161, 114467 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"64500_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41590-019-0397-y","volume":"20","author":"H Baazim","year":"2019","unstructured":"Baazim, H. et al. CD8(+) T cells induce cachexia during chronic viral infection. Nat. Immunol. 20, 701\u2013710 (2019).","journal-title":"Nat. Immunol."},{"key":"64500_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans, C., Chou, J. & Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786\u2013801 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"64500_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.matbio.2018.01.024","volume":"75-76","author":"M Vizovisek","year":"2019","unstructured":"Vizovisek, M., Fonovic, M. & Turk, B. Cysteine cathepsins in extracellular matrix remodeling: extracellular matrix degradation and beyond. Matrix Biol. 75-76, 141\u2013159 (2019).","journal-title":"Matrix Biol."},{"key":"64500_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1963-7","volume":"17","author":"MZI Pranjol","year":"2019","unstructured":"Pranjol, M. Z. I. et al. Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma. J. Transl. Med 17, 216 (2019).","journal-title":"J. Transl. Med"},{"key":"64500_CR33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrc4027","volume":"15","author":"OC Olson","year":"2015","unstructured":"Olson, O. C. & Joyce, J. A. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat. Rev. Cancer 15, 712\u2013729 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"64500_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pharmthera.2015.08.007","volume":"155","author":"DR Sudhan","year":"2015","unstructured":"Sudhan, D. R. & Siemann, D. W. Cathepsin L targeting in cancer treatment. Pharm. Ther. 155, 105\u2013116 (2015).","journal-title":"Pharm. Ther."},{"key":"64500_CR35","doi-asserted-by":"publisher","first-page":"117693512413074","DOI":"10.1177\/11769351241307492","volume":"23","author":"J Lu","year":"2024","unstructured":"Lu, J. et al. Cathepsin L in lung adenocarcinoma: prognostic significance and immunotherapy response through a multi omics perspective. Cancer Inf. 23, 11769351241307492 (2024).","journal-title":"Cancer Inf."},{"key":"64500_CR36","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1242\/jcs.02469","volume":"118","author":"T Reinheckel","year":"2005","unstructured":"Reinheckel, T. et al. The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling. J. Cell Sci. 118, 3387\u20133395 (2005).","journal-title":"J. Cell Sci."},{"key":"64500_CR37","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/onc.2009.466","volume":"29","author":"J Dennemarker","year":"2010","unstructured":"Dennemarker, J. et al. Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis. Oncogene 29, 1611\u20131621 (2010).","journal-title":"Oncogene"},{"key":"64500_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6210","volume":"5","author":"LF Duarte","year":"2014","unstructured":"Duarte, L. F. et al. Histone H3.3 and its proteolytically processed form drive a cellular senescence programme. Nat. Commun. 5, 5210 (2014).","journal-title":"Nat. Commun."},{"key":"64500_CR39","doi-asserted-by":"publisher","unstructured":"S. Chang et al. Hypoxia increases methylated histones to prevent histone clipping and heterochromatin redistribution during Raf-induced senescence. Nucleic Acids Res 53, (2025). https:\/\/doi.org\/10.1093\/nar\/gkae1210","DOI":"10.1093\/nar\/gkae1210"},{"key":"64500_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02197-z","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage. Nat. Genet. https:\/\/doi.org\/10.1038\/s41588-025-02197-z (2025).","journal-title":"Nat. Genet."},{"key":"64500_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2567.2010.03299.x","volume":"131","author":"S Konjar","year":"2010","unstructured":"Konjar, S. et al. Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L. Immunology 131, 257\u2013267 (2010).","journal-title":"Immunology"},{"key":"64500_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/ni844","volume":"3","author":"K Honey","year":"2002","unstructured":"Honey, K. et al. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 3, 1069\u20131074 (2002).","journal-title":"Nat. Immunol."},{"key":"64500_CR43","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1084\/jem.20011904","volume":"195","author":"K Honey","year":"2002","unstructured":"Honey, K., Nakagawa, T., Peters, C. & Rudensky, A. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J. Exp. Med. 195, 1349\u20131358 (2002).","journal-title":"J. Exp. Med."},{"key":"64500_CR44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1126\/science.280.5362.450","volume":"280","author":"T Nakagawa","year":"1998","unstructured":"Nakagawa, T. et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280, 450\u2013453 (1998).","journal-title":"Science"},{"key":"64500_CR45","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jcsm.13073","volume":"14","author":"A Martin","year":"2023","unstructured":"Martin, A., Gallot, Y. S. & Freyssenet, D. Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies. J. Cachexia Sarcopenia Muscle 14, 1150\u20131167 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"64500_CR46","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3945\/ajcn.113.063859","volume":"98","author":"N Tardif","year":"2013","unstructured":"Tardif, N., Klaude, M., Lundell, L., Thorell, A. & Rooyackers, O. Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients. Am. J. Clin. Nutr. 98, 1485\u20131492 (2013).","journal-title":"Am. J. Clin. Nutr."},{"key":"64500_CR47","doi-asserted-by":"publisher","first-page":"C139","DOI":"10.1152\/ajpcell.00773.2024","volume":"328","author":"LJ Novinger","year":"2025","unstructured":"Novinger, L. J., Weinzierl, N. M. & Bonetto, A. Diversity in chemotherapy-induced cachexia. Am. J. Physiol. Cell Physiol. 328, C139\u2013C147 (2025).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"64500_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1586\/14737140.2.1.121","volume":"2","author":"A Tohgo","year":"2002","unstructured":"Tohgo, A., Kumazawa, E., Akahane, K., Asakawa, A. & Inui, A. Anticancer drugs that induce cancer-associated cachectic syndromes. Expert Rev. Anticancer Ther. 2, 121\u2013129 (2002).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"64500_CR49","doi-asserted-by":"publisher","first-page":"e13400","DOI":"10.1111\/apha.13400","volume":"229","author":"AE Hiensch","year":"2020","unstructured":"Hiensch, A. E. et al. Doxorubicin-induced skeletal muscle atrophy: elucidating the underlying molecular pathways. Acta Physiol. (Oxf.) 229, e13400 (2020).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"64500_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65792-6","volume":"10","author":"C Pensec","year":"2020","unstructured":"Pensec, C. et al. Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models. Sci. Rep. 10, 9094 (2020).","journal-title":"Sci. Rep."},{"key":"64500_CR51","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s43018-024-00870-6","volume":"5","author":"K Nutsch","year":"2024","unstructured":"Nutsch, K. et al. TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation. Nat. Cancer 5, 1834\u20131851 (2024).","journal-title":"Nat. Cancer"},{"key":"64500_CR52","doi-asserted-by":"publisher","unstructured":"Song, N. Y. et al. IKKalpha-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines. Proc. Natl Acad. Sci. USA 119, https:\/\/doi.org\/10.1073\/pnas.2120956119 (2022).","DOI":"10.1073\/pnas.2120956119"},{"key":"64500_CR53","doi-asserted-by":"publisher","first-page":"E812","DOI":"10.1073\/pnas.1717520115","volume":"115","author":"NY Song","year":"2018","unstructured":"Song, N. Y. et al. IKKalpha inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways. Proc. Natl Acad. Sci. USA 115, E812\u2013E821 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64500_CR54","doi-asserted-by":"publisher","unstructured":"Arora, G. K. et al. Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin. JCI Insight 3, https:\/\/doi.org\/10.1172\/jci.insight.121221 (2018).","DOI":"10.1172\/jci.insight.121221"},{"key":"64500_CR55","doi-asserted-by":"publisher","first-page":"E743","DOI":"10.1073\/pnas.1714703115","volume":"115","author":"MD Goncalves","year":"2018","unstructured":"Goncalves, M. D. et al. Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proc. Natl Acad. Sci. USA 115, E743\u2013E752 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64500_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111947","volume":"42","author":"JY Kim-Muller","year":"2023","unstructured":"Kim-Muller, J. Y. et al. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia. Cell Rep. 42, 111947 (2023).","journal-title":"Cell Rep."},{"key":"64500_CR57","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s42255-024-01011-0","volume":"6","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Activation of GPR81 by lactate drives tumour-induced cachexia. Nat. Metab. 6, 708\u2013723 (2024).","journal-title":"Nat. Metab."},{"key":"64500_CR58","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand, Y. et al. Immune checkpoint inhibitors in cancer therapy. Curr. Oncol. 29, 3044\u20133060 (2022).","journal-title":"Curr. Oncol."},{"key":"64500_CR59","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41590-023-01538-6","volume":"24","author":"M Buggert","year":"2023","unstructured":"Buggert, M., Price, D. A., Mackay, L. K. & Betts, M. R. Human circulating and tissue-resident memory CD8(+) T cells. Nat. Immunol. 24, 1076\u20131086 (2023).","journal-title":"Nat. Immunol."},{"key":"64500_CR60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","volume":"46","author":"S Cheuk","year":"2017","unstructured":"Cheuk, S. et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity 46, 287\u2013300 (2017).","journal-title":"Immunity"},{"key":"64500_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.728669","volume":"12","author":"EC Reilly","year":"2021","unstructured":"Reilly, E. C. et al. CD49a identifies polyfunctional memory CD8 T cell subsets that persist in the lungs after influenza infection. Front Immunol. 12, 728669 (2021).","journal-title":"Front Immunol."},{"key":"64500_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07053-9","volume":"9","author":"J Smolders","year":"2018","unstructured":"Smolders, J. et al. Tissue-resident memory T cells populate the human brain. Nat. Commun. 9, 4593 (2018).","journal-title":"Nat. Commun."},{"key":"64500_CR63","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","volume":"20","author":"BV Kumar","year":"2017","unstructured":"Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921\u20132934 (2017).","journal-title":"Cell Rep."},{"key":"64500_CR64","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/eji.201040760","volume":"41","author":"A Hanninen","year":"2011","unstructured":"Hanninen, A., Maksimow, M., Alam, C., Morgan, D. J. & Jalkanen, S. Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes. Eur. J. Immunol. 41, 634\u2013644 (2011).","journal-title":"Eur. J. Immunol."},{"key":"64500_CR65","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1016\/j.celrep.2019.05.012","volume":"27","author":"JY Park","year":"2019","unstructured":"Park, J. Y., DiPalma, D. T., Kwon, J., Fink, J. & Park, J. H. Quantitative difference in PLZF protein expression determines iNKT lineage fate and controls innate CD8 T cell generation. Cell Rep. 27, 2548\u20132557 e2544 (2019).","journal-title":"Cell Rep."},{"key":"64500_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9982","volume":"6","author":"S Ishihara","year":"2015","unstructured":"Ishihara, S. et al. Dual functions of Rap1 are crucial for T-cell homeostasis and prevention of spontaneous colitis. Nat. Commun. 6, 8982 (2015).","journal-title":"Nat. Commun."},{"key":"64500_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ni765","volume":"3","author":"E Sebzda","year":"2002","unstructured":"Sebzda, E., Bracke, M., Tugal, T., Hogg, N. & Cantrell, D. A. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat. Immunol. 3, 251\u2013258 (2002).","journal-title":"Nat. Immunol."},{"key":"64500_CR68","doi-asserted-by":"publisher","unstructured":"Paiola, M. et al. Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells. J. Immunother. Cancer 13, https:\/\/doi.org\/10.1136\/jitc-2024-010758 (2025).","DOI":"10.1136\/jitc-2024-010758"},{"key":"64500_CR69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2323052121","volume":"121","author":"H Kalinoski","year":"2024","unstructured":"Kalinoski, H. et al. Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis. Proc. Natl Acad. Sci. USA 121, e2323052121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64500_CR70","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41591-024-02895-x","volume":"30","author":"MF Thomas","year":"2024","unstructured":"Thomas, M. F. et al. Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis. Nat. Med. 30, 1349\u20131362 (2024).","journal-title":"Nat. Med."},{"key":"64500_CR71","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"64500_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","volume":"137","author":"G Gonzalez-Avila","year":"2019","unstructured":"Gonzalez-Avila, G. et al. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit. Rev. Oncol. Hematol. 137, 57\u201383 (2019).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"64500_CR73","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/jcsm.13222","volume":"14","author":"W van de Worp","year":"2023","unstructured":"van de Worp, W. et al. A novel orthotopic mouse model replicates human lung cancer cachexia. J. Cachexia Sarcopenia Muscle 14, 1410\u20131423 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"64500_CR74","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ajpath.2013.06.003","volume":"183","author":"M Freret","year":"2013","unstructured":"Freret, M. et al. Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response. Am. J. Pathol. 183, 893\u2013904 (2013).","journal-title":"Am. J. Pathol."},{"key":"64500_CR75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0165-5728(02)00026-7","volume":"125","author":"GK Pavlath","year":"2002","unstructured":"Pavlath, G. K. Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis. J. Neuroimmunol. 125, 42\u201350 (2002).","journal-title":"J. Neuroimmunol."},{"key":"64500_CR76","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaut.2016.08.004","volume":"75","author":"S Bhattarai","year":"2016","unstructured":"Bhattarai, S. et al. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. J. Autoimmun. 75, 118\u2013129 (2016).","journal-title":"J. Autoimmun."},{"key":"64500_CR77","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.celrep.2019.07.016","volume":"28","author":"EE Talbert","year":"2019","unstructured":"Talbert, E. E. et al. Modeling human cancer-induced cachexia. Cell Rep. 28, 1612\u20131622 e1614 (2019).","journal-title":"Cell Rep."},{"key":"64500_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.94","volume":"5","author":"H Maes","year":"2014","unstructured":"Maes, H. et al. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton. Cell Death Dis. 5, e1127 (2014).","journal-title":"Cell Death Dis."},{"key":"64500_CR79","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/15548627.2024.2395142","volume":"21","author":"J Sun","year":"2025","unstructured":"Sun, J. et al. Hypoxia-induced BNIP3 facilitates the progression and metastasis of uveal melanoma by driving metabolic reprogramming. Autophagy 21, 191\u2013209 (2025).","journal-title":"Autophagy"},{"key":"64500_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06870-9","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. BNIP3-mediated mitophagy boosts the competitive growth of Lenvatinib-resistant cells via energy metabolism reprogramming in HCC. Cell Death Dis. 15, 484 (2024).","journal-title":"Cell Death Dis."},{"key":"64500_CR81","doi-asserted-by":"publisher","unstructured":"Fornelli, C. et al. BNIP3 Downregulation ameliorates muscle atrophy in cancer cachexia. Cancers (Basel) 16, https:\/\/doi.org\/10.3390\/cancers16244133 (2024).","DOI":"10.3390\/cancers16244133"},{"key":"64500_CR82","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","volume":"6","author":"C Mammucari","year":"2007","unstructured":"Mammucari, C. et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6, 458\u2013471 (2007).","journal-title":"Cell Metab."},{"key":"64500_CR83","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1080\/15548627.2024.2360340","volume":"20","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. PGAM5 interacts with and maintains BNIP3 to license cancer-associated muscle wasting. Autophagy 20, 2205\u20132220 (2024).","journal-title":"Autophagy"},{"key":"64500_CR84","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1083\/jcb.201801168","volume":"217","author":"TC Medeiros","year":"2018","unstructured":"Medeiros, T. C., Thomas, R. L., Ghillebert, R. & Graef, M. Autophagy balances mtDNA synthesis and degradation by DNA polymerase POLG during starvation. J. Cell Biol. 217, 1601\u20131611 (2018).","journal-title":"J. Cell Biol."},{"key":"64500_CR85","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.mito.2020.06.004","volume":"53","author":"CA Castellani","year":"2020","unstructured":"Castellani, C. A., Longchamps, R. J., Sun, J., Guallar, E. & Arking, D. E. Thinking outside the nucleus: mitochondrial DNA copy number in health and disease. Mitochondrion 53, 214\u2013223 (2020).","journal-title":"Mitochondrion"},{"key":"64500_CR86","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s11357-021-00351-z","volume":"43","author":"A Herbst","year":"2021","unstructured":"Herbst, A. et al. Skeletal muscle mitochondrial DNA copy number and mitochondrial DNA deletion mutation frequency as predictors of physical performance in older men and women. Geroscience 43, 1253\u20131264 (2021).","journal-title":"Geroscience"},{"key":"64500_CR87","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2005.02.004","volume":"22","author":"D Martinvalet","year":"2005","unstructured":"Martinvalet, D., Zhu, P. & Lieberman, J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 22, 355\u2013370 (2005).","journal-title":"Immunity"},{"key":"64500_CR88","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-019-1162-y","volume":"569","author":"E Perez-Ruiz","year":"2019","unstructured":"Perez-Ruiz, E. et al. Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. Nature 569, 428\u2013432 (2019).","journal-title":"Nature"},{"key":"64500_CR89","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clnu.2007.03.011","volume":"26","author":"RJ Skipworth","year":"2007","unstructured":"Skipworth, R. J., Stewart, G. D., Dejong, C. H., Preston, T. & Fearon, K. C. Pathophysiology of cancer cachexia: much more than host\u2013tumour interaction?. Clin. Nutr. 26, 667\u2013676 (2007).","journal-title":"Clin. Nutr."},{"key":"64500_CR90","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1158\/2159-8290.CD-23-1509","volume":"14","author":"Y Wu","year":"2024","unstructured":"Wu, Y., Zou, Q., Jiang, P. & Gao, Q. Tumor\u2013host cometabolism collaborates to shape cancer immunity. Cancer Discov. 14, 653\u2013657 (2024).","journal-title":"Cancer Discov."},{"key":"64500_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fphys.2019.00041","volume":"10","author":"F Penna","year":"2019","unstructured":"Penna, F. et al. The skeletal muscle as an active player against cancer cachexia. Front. Physiol. 10, 41 (2019).","journal-title":"Front. Physiol."},{"key":"64500_CR92","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tem.2021.03.007","volume":"32","author":"T Siff","year":"2021","unstructured":"Siff, T., Parajuli, P., Razzaque, M. S. & Atfi, A. Cancer-mediated muscle cachexia: etiology and clinical management. Trends Endocrinol. Metab. 32, 382\u2013402 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"64500_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115234","volume":"44","author":"AL Cote","year":"2025","unstructured":"Cote, A. L., Munger, C. J. & Ringel, A. E. Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions. Cell Rep. 44, 115234 (2025).","journal-title":"Cell Rep."},{"key":"64500_CR94","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1200\/JCO.2010.28.4257","volume":"28","author":"SS McAllister","year":"2010","unstructured":"McAllister, S. S. & Weinberg, R. A. Tumor-host interactions: a far-reaching relationship. J. Clin. Oncol. 28, 4022\u20134028 (2010).","journal-title":"J. Clin. Oncol."},{"key":"64500_CR95","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/jclinpath-2011-200138","volume":"65","author":"R Salaroli","year":"2012","unstructured":"Salaroli, R. et al. Validity of internal expression of the major histocompatibility complex class I in the diagnosis of inflammatory myopathies. J. Clin. Pathol. 65, 14\u201319 (2012).","journal-title":"J. Clin. Pathol."},{"key":"64500_CR96","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju, K. et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc. Natl Acad. Sci. USA 97, 9209\u20139214 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64500_CR97","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/jcsm.12864","volume":"13","author":"Y Luan","year":"2022","unstructured":"Luan, Y. et al. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study. J. Cachexia Sarcopenia Muscle 13, 1289\u20131301 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"64500_CR98","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.cmet.2025.01.018","volume":"37","author":"Q Cui","year":"2025","unstructured":"Cui, Q. et al. MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia. Cell Metab. 37, 954\u2013970 e958 (2025).","journal-title":"Cell Metab."},{"key":"64500_CR99","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s12094-015-1424-6","volume":"18","author":"F Cui","year":"2016","unstructured":"Cui, F. et al. Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer. Clin. Transl. Oncol. 18, 722\u2013727 (2016).","journal-title":"Clin. Transl. Oncol."},{"key":"64500_CR100","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70364","volume":"29","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. CTSL promotes autophagy in laryngeal cancer through the IL6-JAK-STAT3 signalling pathway. J. Cell. Mol. Med. 29, e70364 (2025).","journal-title":"J. Cell. Mol. Med."},{"key":"64500_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1158087","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer. Front. Oncol. 13, 1158087 (2023).","journal-title":"Front. Oncol."},{"key":"64500_CR102","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.3748\/wjg.v30.i47.5032","volume":"30","author":"LX Xiao","year":"2024","unstructured":"Xiao, L. X. et al. Macrophage-derived cathepsin L promotes epithelial\u2013mesenchymal transition and M2 polarization in gastric cancer. World J. Gastroenterol. 30, 5032\u20135054 (2024).","journal-title":"World J. Gastroenterol."},{"key":"64500_CR103","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ncb2171","volume":"13","author":"PA Kreuzaler","year":"2011","unstructured":"Kreuzaler, P. A. et al. Stat3 controls lysosomal-mediated cell death in vivo. Nat. Cell Biol. 13, 303\u2013309 (2011).","journal-title":"Nat. Cell Biol."},{"key":"64500_CR104","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/ncb3043","volume":"16","author":"TJ Sargeant","year":"2014","unstructured":"Sargeant, T. J. et al. Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization. Nat. Cell Biol. 16, 1057\u20131068 (2014).","journal-title":"Nat. Cell Biol."},{"key":"64500_CR105","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/sj.onc.1209196","volume":"25","author":"D Jean","year":"2006","unstructured":"Jean, D., Rousselet, N. & Frade, R. Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms. Oncogene 25, 1474\u20131484 (2006).","journal-title":"Oncogene"},{"key":"64500_CR106","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1515\/hsz-2023-0213","volume":"405","author":"M Grozdanic","year":"2024","unstructured":"Grozdanic, M. et al. Cathepsin L-mediated EGFR cleavage affects intracellular signalling pathways in cancer. Biol. Chem. 405, 283\u2013296 (2024).","journal-title":"Biol. Chem."},{"key":"64500_CR107","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/aps.2014.148","volume":"36","author":"N Yang","year":"2015","unstructured":"Yang, N., Wang, P., Wang, W. J., Song, Y. Z. & Liang, Z. Q. Inhibition of cathepsin L sensitizes human glioma cells to ionizing radiation in vitro through NF-kappaB signaling pathway. Acta Pharm. Sin. 36, 400\u2013410 (2015).","journal-title":"Acta Pharm. Sin."},{"key":"64500_CR108","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/aps.2016.93","volume":"37","author":"ML Han","year":"2016","unstructured":"Han, M. L. et al. Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells. Acta Pharm. Sin. 37, 1606\u20131622 (2016).","journal-title":"Acta Pharm. Sin."},{"key":"64500_CR109","doi-asserted-by":"publisher","first-page":"C65","DOI":"10.1152\/ajpcell.00082.2008","volume":"296","author":"X Zheng","year":"2009","unstructured":"Zheng, X. et al. Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism. Am. J. Physiol. Cell Physiol. 296, C65\u2013C74 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"64500_CR110","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.it.2020.04.006","volume":"41","author":"B Chazaud","year":"2020","unstructured":"Chazaud, B. Inflammation and skeletal muscle regeneration: leave it to the macrophages!. Trends Immunol. 41, 481\u2013492 (2020).","journal-title":"Trends Immunol."},{"key":"64500_CR111","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2005.08.002","volume":"26","author":"F Mourkioti","year":"2005","unstructured":"Mourkioti, F. & Rosenthal, N. IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol. 26, 535\u2013542 (2005).","journal-title":"Trends Immunol."},{"key":"64500_CR112","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","volume":"155","author":"D Burzyn","year":"2013","unstructured":"Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282\u20131295 (2013).","journal-title":"Cell"},{"key":"64500_CR113","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen, L. et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J. Exp. Med. 201, 591\u2013601 (2005).","journal-title":"J. Exp. Med."},{"key":"64500_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-015-0058-2","volume":"5","author":"PL Huang","year":"2015","unstructured":"Huang, P. L. et al. Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis. Skelet. Muscle 5, 33 (2015).","journal-title":"Skelet. Muscle"},{"key":"64500_CR115","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0960-8966(93)90023-D","volume":"3","author":"K Nakamura","year":"1993","unstructured":"Nakamura, K., Arahata, K., Ishiura, S., Osame, M. & Sugita, H. Degradative activity of granzyme A on skeletal muscle proteins in vitro: a possible molecular mechanism for muscle fiber damage in polymyositis. Neuromuscul. Disord. 3, 303\u2013310 (1993).","journal-title":"Neuromuscul. Disord."},{"key":"64500_CR116","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels, N. et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Investig. 97, 2905\u20132910 (1996).","journal-title":"J. Clin. Investig."},{"key":"64500_CR117","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2017.11.025","volume":"48","author":"J Kim","year":"2018","unstructured":"Kim, J. et al. Innate-like cytotoxic function of bystander-activated CD8(+) T cells is associated with liver injury in acute hepatitis A. Immunity 48, 161\u2013173 e165 (2018).","journal-title":"Immunity"},{"key":"64500_CR118","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI85996","volume":"126","author":"SA Younes","year":"2016","unstructured":"Younes, S. A. et al. IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. J. Clin. Investig. 126, 2745\u20132756 (2016).","journal-title":"J. Clin. Investig."},{"key":"64500_CR119","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.micinf.2004.01.008","volume":"6","author":"K Onishi","year":"2004","unstructured":"Onishi, K. et al. Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection. Microbes Infect. 6, 468\u2013474 (2004).","journal-title":"Microbes Infect."},{"key":"64500_CR120","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni, Y. et al. Bystander CD8(+) T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575\u2013579 (2018).","journal-title":"Nature"},{"key":"64500_CR121","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 15, 234\u2013248 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"64500_CR122","doi-asserted-by":"publisher","first-page":"C935","DOI":"10.1152\/ajpcell.00458.2023","volume":"326","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. HIF-1 contributes to autophagy activation via BNIP3 to facilitate renal fibrosis in hypoxia in vitro and UUO in vivo. Am. J. Physiol. Cell Physiol. 326, C935\u2013C947 (2024).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"64500_CR123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"64500_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).","journal-title":"BMC Bioinform."},{"key":"64500_CR125","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41592-024-02235-4","volume":"21","author":"W Hou","year":"2024","unstructured":"Hou, W. & Ji, Z. Assessing GPT-4 for cell type annotation in single-cell RNA-seq analysis. Nat. Methods 21, 1462\u20131465 (2024).","journal-title":"Nat. Methods"},{"key":"64500_CR126","doi-asserted-by":"publisher","unstructured":"Son, K. 202397101\/Ctsl: First release of Ctsl project: initial code base and documentation. GitHub. Zenodo https:\/\/doi.org\/10.5281\/zenodo.17102995 (2025).","DOI":"10.5281\/zenodo.17102995"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64500-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:02:53Z","timestamp":1764345773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64500-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64500"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64500-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10706"}}